Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesInterCure Ltd.

InterCure Ltd.

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
3.47 USD 0.17 ( 5.31%)
Last update at 2026-11-06T21:00:00Z
VOLUME
17920
Market Cap
76.97M

Momentum Score

…

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
3.27
Low
3.47
High
52 Week Price Range
3.40
Low
8.45
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

InterCure Ltd. is an Israeli medical cannabis company that cultivates, processes and sells cannabis-derived products and is listed on NASDAQ as INCR.US. Long-term growth drivers include rising medical cannabis adoption, potential regulatory reform and international expansion that could support product and volume growth, making it a way to access the regulated medicinal cannabis sector.
Principal risks are regulatory and legal uncertainty across jurisdictions, intense competition and execution and financing risk for scaling operations abroad.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
3.29
Dividend Yield
-
Revenue TTM
243.12M
Revenue Per Share
4.83
Gross Profit TTM
40.61M
Debt / Equity
0.46
ROE
-9.27%
Net Debt
136.55M
ROCE
-5.13%
Diluted EPS TTM
-1.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -44.10M -87.32M -61.28M 43.84M 18.74M
Minority interest 1.07M 5.00M 1.57M 1.07M -2.60M
Net income -35.71M -67.80M -61.96M 44.82M 7.30M
Selling general administrative 60.15M 62.92M 64.30M 91.72M 30.73M
Selling and marketing expenses 20.26M 21.71M 21.94M 5.60M 23.21M
Gross profit 33.18M 30.23M 105.09M 155.08M 91.13M
Reconciled depreciation 17.15M 15.37M 13.17M 11.70M 7.39M
Ebit -24.44M -66.68M -37.07M 52.80M 28.19M
Ebitda -7.29M -51.31M -23.90M 64.50M 37.58M
Depreciation and amortization 17.15M 15.37M 13.17M 11.70M 9.39M
Operating income 6.73M -67.21M -41.57M 52.80M 28.19M
Other operating expenses 263.47M 306.05M 397.12M 335.75M 186.65M
Interest expense 19.66M 20.64M 24.22M 14.69M 5.04M
Tax provision -7.32M -14.53M 2.25M 0.09M 11.44M
Interest income 1.55M 2.70M 5.38M 0.84M 0.13M
Net interest income -18.28M -20.09M -19.67M -13.85M -4.92M
Income tax expense -7.32M -14.53M 2.25M 0.09M 11.44M
Total revenue 270.20M 238.84M 355.55M 388.68M 219.68M
Total operating expenses 26.45M 97.44M 146.66M 102.15M 58.10M
Cost of revenue 237.02M 208.61M 250.46M 233.60M 128.55M
Total other income expense net -50.84M -20.11M -19.72M -8.96M -9.45M
Net income from continuing ops -36.78M -72.79M -63.53M 43.75M 7.30M
Net income applicable to common shares - - - - 4.69M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 690.55M 762.57M 786.61M 958.01M 686.32M
Other current assets 7.54M 7.32M 151.78M 18.25M 34.20M
Total liab 294.19M 364.90M 329.55M 436.53M 227.13M
Total stockholder equity 396.52M 396.97M 455.11M 501.31M 448.03M
Other current liab 42.16M 74.99M 4.08M 46.22M 50.62M
Common stock 675.60M 658.60M 643.16M 632.02M 623.57M
Capital stock 675.60M 658.60M 643.16M 632.02M 623.57M
Retained earnings -314.62M -277.58M -204.00M -141.65M -186.47M
Other liab - - - - 0.22M
Good will 219.19M 224.59M 221.08M 284.18M 258.07M
Other assets - - - - 3.02M
Cash 46.47M 78.32M 101.14M 232.59M 196.22M
Total current liabilities 214.37M 226.75M 225.87M 312.72M 193.58M
Current deferred revenue - - 50.51M 8.06M 2.90M
Net debt 136.55M 133.09M 94.54M 22.57M -87.31M
Short term debt 104.06M 74.22M 92.83M 132.37M 75.59M
Short long term debt 99.80M 69.44M 88.19M 128.03M 72.28M
Short long term debt total 183.01M 211.40M 195.68M 255.16M 108.91M
Other stockholder equity 19.59M - - 8.54M 8.54M
Property plant equipment - - - - 86.51M
Total current assets 316.75M 391.80M 418.80M 507.49M 336.16M
Long term investments 1.02M 2.15M 1.92M 42.56M 2.56M
Net tangible assets - - - - 189.96M
Short term investments 0.21M 0.33M 0.19M 0.20M 0.33M
Net receivables 154.47M 180.50M 170.78M 129.95M 37.53M
Long term debt 59.46M 113.98M 82.20M 99.68M 11.95M
Inventory 108.06M 125.33M 106.29M 126.50M 67.88M
Accounts payable 68.14M 77.54M 78.44M 126.07M 64.47M
Accumulated other comprehensive income 15.95M 15.95M 15.95M 2.39M 2.39M
Non currrent assets other 4.79M 0.42M 22.65M - 0.00M
Non current assets total 373.81M 370.77M 367.81M 450.51M 350.17M
Capital lease obligations 23.75M 27.99M 25.28M 27.45M 24.68M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 17.69M 4.77M -142.50M -1.25M
Change to liabilities - - - - 2.79M
Total cashflows from investing activities -1.99M 17.69M 4.77M - -65.21M
Net borrowings -29.13M 7.74M -61.98M - 65.83M
Total cash from financing activities -46.66M 26.45M -82.89M 120.45M 203.06M
Change to operating activities - - - - 2.64M
Net income -36.78M -72.79M -63.53M 43.75M 7.29M
Change in cash -31.85M -22.82M -131.45M 36.37M 158.33M
Begin period cash flow 78.32M 101.14M 232.59M 196.22M 37.89M
End period cash flow 46.47M 78.32M 101.14M 232.59M 196.22M
Total cash from operating activities 16.84M -66.93M -53.63M 51.27M 25.02M
Issuance of capital stock 1.50M 34.00M 0.00M 0.00M 128.73M
Depreciation 17.15M 15.37M 13.17M 11.70M 7.39M
Other cashflows from investing activities -0.11M 21.66M 11.59M - -23.50M
Dividends paid 0.00M 0.00M 0.00M 0.00M -
Change to inventory 15.95M -17.44M 40.21M -75.99M -17.89M
Change to account receivables 9.29M 13.26M -23.49M -18.29M 8.39M
Other cashflows from financing activities -19.03M -15.29M -20.91M 246.19M 83.96M
Change to netincome - - - - 14.59M
Capital expenditures 3.55M 4.38M 2.62M 19.74M 14.03M
Change in working capital 18.88M -9.19M -43.55M -3.02M -1.65M
Stock based compensation 2.43M 2.28M 2.59M 8.91M 6.45M
Other non cash items 22.49M 11.94M 35.44M -10.16M -5.91M
Free cash flow 13.29M -71.30M -56.25M 31.52M 10.99M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
INCR
InterCure Ltd.		 0.17
5.31%		 3.47 - 6.18 0.62 0.59 1.37 5.29
MKKGY
Merck KGaA ADR		 -0.22
0.66%		 33.17 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.76
1.62%		 167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.17
0.80%		 21.02 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.85 - 10.66 0.01 1.16 2.94 23.11

Profile*

InterCure Ltd.

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670

972 7 746 05012

https://www.intercure.co

285

Name Title Year Born
Mr. Alexander Rabinovitch CEO & Director 1971
Mr. Amos Cohen Chief Financial Officer 1979
Mr. Rami Levy Chief Operating Officer of Canndoc 1965
Mr. Omri Batzir Corp. Controller NA
Advocate Asaf Ohayon Co-Founder & Co-CEO of Cannolam Ltd. 1989
Mr. Ori-Moni Mimon Co-Founder & Co-CEO of Cannolam Ltd. 1988
Mr. Alexander Rabinovich CEO & Director 1971
Einat Zehavi Vice President of Sales NA
Mr. Omri Batzir Corporate Controller NA
Mr. Alexander Rabinovich Founder, CEO & Chairman 1971

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…